FundedIQ
Biotechnology

Remepy

Remepy is biotechnology research pioneering hybrid drugs.

www.remepy.com Ramat Gan, Israel 11-50 employees
Total raised
$36.0M
Rounds
1
Latest
Series A
Aug 2026

Remepy is biotechnology research pioneering hybrid drugs.

Remepy has raised $36.0M across 1 round. Its most recent round was a Series A of $36.0M in Aug 2026. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with FundedIQ

1 round on record.

Date
Round
Amount
Lead investor
Aug 12, 2026
Series A
$36.0M

Unlock the lead investor and full details for this round.

Start 14-day free trial →

People

Unlock with FundedIQ

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles, verified email addresses and LinkedIn profiles.

Start 14-day free trial →

Remepy is featured in

Similar companies

Corma

Corma develops foundation models and artificial intelligence systems for defensive cybersecurity.

Seed $60.0M
Faye

Faye provides whole-trip travel coverage and care that brings out the best in each journey with industry-leading technology that enables smarter, faster, smoother assistance and claims resolutions. Our robust travel insurance covers your health, your trip, your stuff, and even your pet, via an app that provides real-time proactive solutions, quick reimbursements and 24/7 customer experience specialists who turn travel mishaps into laugh-about-it-later memories. Join our team of travel and insurance experts as we set a new standard by overdelivering in an industry oftentimes synonymous with doing the opposite.

Series C $50.0M
Oligo Security

By utilising runtime application context and leveraging the most exact open source security solution available, Oligo, performance and stability are maintained. Customers who use Oligo may save time and concentrate on the pertinent runtime vulnerabilities, which reduces the effort of reacting to security alerts by roughly 85%.

Series C $60.0M
QuantHealth

QuantHealth is an organization that produces software using artificial intelligence technology for drug development data. This software is utilized for conducting patient-focused medication simulations, with the aim of expediting and reducing the risks associated with drug development. By merging data from various sources within clinical and drug development fields, the company's software can forecast how patients will respond to both existing and innovative treatments. This enables pharmaceutical and biotechnology clients to conduct different versions of their clinical trials, enhancing trial design and boosting the chances of successful trials. As a result, QuantHealth aids in uncovering new clinical prospects and optimization strategies.

Series B $45.0M
Above Security

Above Security provides cybersecurity services focused on threat detection, risk management, and compliance support for organizations. Its offerings include managed security services, vulnerability assessments, penetration testing, and incident response to help identify and address security risks. The company also delivers security operations center capabilities that monitor and analyze network activity to detect potential threats. In addition, it supports governance, risk, and compliance programs by helping organizations align with regulatory requirements and security frameworks. Its services are designed to assist businesses in maintaining visibility over their systems and improving overall security posture.

Series Unknown
Zenity

Zenity is a leading company that assists businesses in securing and managing AI Agents and Apps. The era of AI has given business users unprecedented control over the development of business applications, with AI Agents now being created and controlled by these users. However, many existing security tools are not equipped to handle the unique challenges posed by business-led development. Zenity's platform is designed with a strong emphasis on security, focusing on Visibility, Risk Assessment, and Governance. As a founding member of the OWASP Top 10 project and the Gen AI Attacks Matrix, Zenity takes a collaborative approach to address security concerns in low-code/no-code development. Compliant with SOC 2 Type 2 and GDPR regulations, Zenity's platform helps businesses understand their apps, mitigate risks, comply with regulations, and support business-led development.

Series C $115M
Xsight Labs

Xsight Labs is an Israeli company that develops technology for accelerating the next-generation, cloud-based, data-intensive workloads such as machine learning by offering new chipset designs that enhance scalability, performance and efficiency.

Series E $300M
Cytactic

Cytactic is a company that specializes in cyber crisis management, offering services such as advisory, simulations, and assessments.

Seed
groundcover

groundcover is a K8s application monitoring solution that reinvents the domain with eBPF.

Series C $100M
Hush Security

Hush Security is a cybersecurity company specializing in eliminating static secrets like API keys and credentials.

Series A $30.0M
Mate

Mate provides an AI-powered SOC solution that learns from an organization’s best analysts and builds a contextual data.

Series A $35.0M
Plantopia Bio

Plantopia Bio is an ag-tech firm developing a molecular technology platform that enables external gene activation in plants.

Series Unknown $9.0M
14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.